(Albany, USA) DelveInsight’s “Candidiasis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Candidiasis, historical and forecasted epidemiology as well as the Candidiasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Candidiasis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Candidiasis market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Candidiasis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Candidiasis market.
Request for a Free Sample Report @ Candidiasis Market Forecast
Some facts of the Candidiasis Market Report are:
According to DelveInsight, Candidiasis market size is expected to grow at a decent CAGR by 2032.
Leading Candidiasis companies working in the market are Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Scynexis, Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc., Pfizer, and others.
The Candidiasis diagnosed incident population in the 7MM countries was estimated to be approximately 41,000+ cases in 2022, with the United States contributing approximately 23,000+ cases. Among EU4 and the UK, it was observed that Spain had the highest incidence rate of Candidiasis.
The United States is anticipated to dominate the Candidiasis market among the 7MM during the forecast period.
In September 2021, Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, presented new clinical and non-clinical data for its Rezafungin in two poster presentations at the 10th Congress on Trends in Medical Mycology (TIMM) Webinar which took place in Aberdeen, Scotland. Rezafungin is a novel once-weekly echinocandin which is being developed for both the treatment and prevention of serious fungal infections, such as candidemia and invasive candidiasis. Hence, product innovation is expected to boost the market growth.
Candidiasis, also known as a yeast infection, is a fungal infection caused by the overgrowth of a type of yeast called Candida. Candida is commonly found on the skin, in the mouth, gastrointestinal tract, and in the private area in small amounts, but certain factors can disrupt the natural balance and lead to an overgrowth of this yeast.
Symptoms of candidiasis can vary depending on the site of infection. In oral candidiasis, also known as thrush, white patches may appear on the tongue, inner cheeks, or roof of the mouth, which can be painful or cause difficulty in swallowing.
Risk factors for candidiasis include weakened immune system, diabetes, pregnancy, use of certain medications (such as antibiotics, corticosteroids, or oral contraceptives), poor oral hygiene, and wearing tight-fitting, non-breathable clothing.
Learn more about Candidiasis treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/candidiasis-market
The Candidiasis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Candidiasis market trends by analyzing the impact of current Candidiasis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Candidiasis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Candidiasis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Candidiasis market in 7MM is expected to witness a major change in the study period 2019-2032.
The Candidiasis epidemiology section provides insights into the historical and current Candidiasis patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Candidiasis market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Candidiasis Epidemiology @ https://www.delveinsight.com/sample-request/candidiasis-market
Candidiasis Drugs Uptake
This section focuses on the uptake rate of the potential Candidiasis drugs recently launched in the Candidiasis market or expected to be launched in 2019-2032. The analysis covers the Candidiasis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Candidiasis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Candidiasis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Candidiasis Pipeline Development Activities
The Candidiasis report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Candidiasis key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Candidiasis pipeline development activities @ https://www.delveinsight.com/sample-request/candidiasis-market
Candidiasis Therapeutics Assessment
Major key companies are working proactively in the Candidiasis Therapeutics market to develop novel therapies which will drive the Candidiasis treatment markets in the upcoming years are Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Scynexis, Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc., Pfizer, and others.
Learn more about the emerging Candidiasis therapies & key companies @ https://www.delveinsight.com/sample-request/candidiasis-market
Candidiasis Report Key Insights
1. Candidiasis Patient Population
2. Candidiasis Market Size and Trends
3. Key Cross Competition in the Candidiasis Market
4. Candidiasis Market Dynamics (Key Drivers and Barriers)
5. Candidiasis Market Opportunities
6. Candidiasis Therapeutic Approaches
7. Candidiasis Pipeline Analysis
8. Candidiasis Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Candidiasis Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Candidiasis Competitive Intelligence Analysis
4. Candidiasis Market Overview at a Glance
5. Candidiasis Disease Background and Overview
6. Candidiasis Patient Journey
7. Candidiasis Epidemiology and Patient Population
8. Candidiasis Treatment Algorithm, Current Treatment, and Medical Practices
9. Candidiasis Unmet Needs
10. Key Endpoints of Candidiasis Treatment
11. Candidiasis Marketed Products
12. Candidiasis Emerging Therapies
13. Candidiasis Seven Major Market Analysis
14. Attribute Analysis
15. Candidiasis Market Outlook (7 major markets)
16. Candidiasis Access and Reimbursement Overview
17. KOL Views on the Candidiasis Market
18. Candidiasis Market Drivers
19. Candidiasis Market Barriers
21. DelveInsight Capabilities
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States